Filter
1218
Filtered Results: 1218
Text search:
pharmaceutical
performance
Featured
Recommendations
108
New Publications
381
Language
Document type
No document type
717
Studies & Reports
187
Guidelines
161
Strategic & Response Plan
59
Manuals
56
Training Material
17
Fact sheets
10
Situation Updates
8
Resource Platforms
3
Countries / Regions
Ethiopia
59
India
55
Kenya
51
Global
40
Uganda
35
Nigeria
31
South Africa
31
Liberia
29
Sierra Leone
26
Rwanda
23
Ghana
22
Tanzania
22
Zambia
22
Western and Central Europe
21
Nepal
19
Namibia
19
Malawi
18
Bangladesh
17
Africa
16
Ukraine
13
Philippines
12
Cambodia
12
Zimbabwe
11
Eastern Europe
11
Indonesia
11
Lesotho
10
Syria
10
Latin America and the Carribbean
10
Congo, Democratic Republic of
9
West and Central Africa
9
Myanmar / Burma
9
Botswana
8
South–East Asia Region
7
Cameroon
6
Senegal
6
East and Southern Africa
6
Eswatini/ Swaziland
6
Benin
5
Thailand
4
Guinea
4
Asia
4
Albania
3
Burkina Faso
3
Germany
3
Middle East and North Africa
3
Western Pacific Region
3
Eastern Europe and Central Asia
3
Brazil
3
South Sudan
3
China
2
Jordan
2
Jamaica
2
Lebanon
2
Egypt
2
Iraq
2
Pakistan
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
Australia
1
Chile
1
Iran
1
Fiji
1
Laos
1
Kyrgyzstan
1
Niger
1
Afghanistan
1
Peru
1
Bulgaria
1
Mozambique
1
Haiti
1
Lithuania
1
Ireland
1
Saudi Arabia
1
North America
1
Japan
1
United Kingdom
1
Southern Africa
1
Vietnam
1
Papua New Guinea
1
Moldova
1
Sudan
1
Mali
1
Chad
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
572
Clinical Guidelines
71
Public Health
69
Key Resources
47
Pharmacy & Technologies
27
Women & Child Health
25
Capacity Building
11
Toolboxes
Pharmacy
98
COVID-19
77
AMR
77
TB
73
Mental Health
57
HIV
48
Rapid Response
34
Planetary Health
29
NCDs
26
Caregiver
25
NTDs
24
Conflict
21
Global Health Education
21
Health Financing Toolbox
20
Refugee
8
Ebola
8
Polio
8
Specific Hazards
7
Disability
5
Natural Hazards
4
Cholera
2
Health Financing
2
Social Ethics
1
Zika
1
Advances have been made through expanded interventions delivered through five public health approaches: innovative and intensified disease management; preventive chemotherapy; vector ecology and management; veterinary public health services; and the provision of safe water, sanitation and hygiene. I...
Situational Analysis: 13-23 October 2014
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Prepared as an outcome of ICMR Subcommittee on Breast Cancer |.This consensus document on management of breast cancers summarizes the
modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It also inter...
Prepared as an outcome of ICMR Subcommittee on Buccal Mucosa Cancer | This consensus document on management of Buccal Mucosa cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. ...
Prepared as an outcome of ICMR Subcommittee on Cancer Cervix | This consensus document on management of cervix cancer summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It also interwe...
Prepared as an outcome of ICMR Subcommittee on Colorectal Cancer | Coordinated by Division of Non Communicable Diseases | This Consensus Document on Management of Colorectal Cancer summarizes the modalities of treatment including the site-specific anti-cancer therapies,
supportive and palliative ca...
Prepared as an outcome of ICMR Subcommittee on Esophageal Cancer | This consensus document on management of esophageal cancers
summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It a...
Prepared as an outcome of ICMR Subcommittee on Gastric Cancer | This consensus document on Management of Gallbladder cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It also ...
Prepared as an outcome of ICMR Subcommittee on Larynx & Hypopharynx Cancers | This consensus document on management of larynx and hypopharynx cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and re...
Prepared as an outcome of ICMR Subcommittee on Multiple Myeloma | This consensus document on management of multiple myeloma summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It also i...
Prepared as an outcome of ICMR Subcommittee on Non Hodgkin’s Lymphoma (High Grade) | This consensus document on management of non- hodgkin’s lymphoma – high grade summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molec...
Prepared as an outcome of ICMR Subcommittee on Soft Tissue Sarcoma and Osteosarcoma | This consensus document on Management of Soft Tissue Sarcoma and Osteosarcoma summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular ...
An update from the EU Early Warning System
Available in English, French, Spanish, Russian, Chinese, Arabic and Portugues
This is an update of a seven-year TB and Leprosy national strategic plan (TBL-NSP), which extends from 2013 to 2020. The update focuses on the plan covering from 2017-20 and is based on the 2017 external mid-term programme review key findings and recommendations; the global and national End TB strat...
Zambia Essential Medicines List (ZEML) 05
recommended
2020 Version
